AAPL   374.15 (+2.76%)
MSFT   210.84 (+2.22%)
FB   239.95 (+2.80%)
AMZN   3,019.03 (+4.45%)
CGC   16.95 (+3.04%)
BABA   240.08 (+7.37%)
MU   50.71 (+1.77%)
T   30.29 (+0.70%)
ACB   12.37 (+0.81%)
GILD   76.88 (+0.69%)
DIS   112.95 (+0.69%)
BAC   23.56 (+1.16%)
BA   183.29 (+1.37%)
AAPL   374.15 (+2.76%)
MSFT   210.84 (+2.22%)
FB   239.95 (+2.80%)
AMZN   3,019.03 (+4.45%)
CGC   16.95 (+3.04%)
BABA   240.08 (+7.37%)
MU   50.71 (+1.77%)
T   30.29 (+0.70%)
ACB   12.37 (+0.81%)
GILD   76.88 (+0.69%)
DIS   112.95 (+0.69%)
BAC   23.56 (+1.16%)
BA   183.29 (+1.37%)
AAPL   374.15 (+2.76%)
MSFT   210.84 (+2.22%)
FB   239.95 (+2.80%)
AMZN   3,019.03 (+4.45%)
CGC   16.95 (+3.04%)
BABA   240.08 (+7.37%)
MU   50.71 (+1.77%)
T   30.29 (+0.70%)
ACB   12.37 (+0.81%)
GILD   76.88 (+0.69%)
DIS   112.95 (+0.69%)
BAC   23.56 (+1.16%)
BA   183.29 (+1.37%)
AAPL   374.15 (+2.76%)
MSFT   210.84 (+2.22%)
FB   239.95 (+2.80%)
AMZN   3,019.03 (+4.45%)
CGC   16.95 (+3.04%)
BABA   240.08 (+7.37%)
MU   50.71 (+1.77%)
T   30.29 (+0.70%)
ACB   12.37 (+0.81%)
GILD   76.88 (+0.69%)
DIS   112.95 (+0.69%)
BAC   23.56 (+1.16%)
BA   183.29 (+1.37%)
Log in

NYSE:HRCHill-Rom Stock Price, Forecast & News

$114.40
+2.83 (+2.54 %)
(As of 07/6/2020 01:15 PM ET)
Add
Compare
Today's Range
$113.02
Now: $114.40
$114.50
50-Day Range
$94.50
MA: $101.12
$111.57
52-Week Range
$72.29
Now: $114.40
$117.50
Volume10,986 shs
Average Volume784,187 shs
Market Capitalization$7.61 billion
P/E Ratio52.48
Dividend Yield0.79%
Beta0.72
Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as blood pressure, physical assessment, vital signs monitoring, diagnostic cardiopulmonary, diabetic retinopathy screening, and thermometry products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, and Monarch systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables; and operating room surgical safety and accessory products, which comprise scalpels and blades, light handle systems, skin markers, and other disposable products. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.
Read More
Hill-Rom logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.83 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP43147510
Phone312-819-7200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.91 billion
Cash Flow$8.37 per share
Book Value$23.55 per share

Profitability

Net Income$152.20 million

Miscellaneous

Employees10,000
Market Cap$7.61 billion
Next Earnings Date7/31/2020 (Confirmed)
OptionableOptionable

Receive HRC News and Ratings via Email

Sign-up to receive the latest news and ratings for HRC and its competitors with MarketBeat's FREE daily newsletter.

Hill-Rom (NYSE:HRC) Frequently Asked Questions

How has Hill-Rom's stock been impacted by COVID-19 (Coronavirus)?

Hill-Rom's stock was trading at $89.15 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, HRC shares have increased by 28.0% and is now trading at $114.08. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Hill-Rom?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hill-Rom in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Hill-Rom.

When is Hill-Rom's next earnings date?

Hill-Rom is scheduled to release its next quarterly earnings announcement on Friday, July 31st 2020. View our earnings forecast for Hill-Rom.

How can I listen to Hill-Rom's earnings call?

Hill-Rom will be holding an earnings conference call on Friday, July 31st at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Hill-Rom's earnings last quarter?

Hill-Rom Holdings, Inc. (NYSE:HRC) issued its quarterly earnings results on Friday, May, 1st. The medical technology company reported $1.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.15 by $0.13. The medical technology company earned $723.20 million during the quarter, compared to the consensus estimate of $701.72 million. Hill-Rom had a return on equity of 22.60% and a net margin of 5.04%. The company's revenue for the quarter was up 1.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.14 earnings per share. View Hill-Rom's earnings history.

How often does Hill-Rom pay dividends? What is the dividend yield for Hill-Rom?

Hill-Rom announced a quarterly dividend on Thursday, May 7th. Stockholders of record on Friday, June 19th will be paid a dividend of $0.22 per share on Tuesday, June 30th. This represents a $0.88 annualized dividend and a dividend yield of 0.77%. The ex-dividend date is Thursday, June 18th. View Hill-Rom's dividend history.

What price target have analysts set for HRC?

5 equities research analysts have issued 12-month target prices for Hill-Rom's stock. Their forecasts range from $125.00 to $131.00. On average, they anticipate Hill-Rom's stock price to reach $126.20 in the next twelve months. This suggests a possible upside of 10.6% from the stock's current price. View analysts' price targets for Hill-Rom.

Has Hill-Rom been receiving favorable news coverage?

Press coverage about HRC stock has trended negative on Monday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Hill-Rom earned a news sentiment score of -2.1 on InfoTrie's scale. They also assigned headlines about the medical technology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about Hill-Rom.

Are investors shorting Hill-Rom?

Hill-Rom saw a decrease in short interest in June. As of June 30th, there was short interest totaling 1,710,000 shares, a decrease of 21.2% from the June 15th total of 2,170,000 shares. Based on an average daily volume of 734,900 shares, the days-to-cover ratio is presently 2.3 days. Approximately 2.6% of the company's stock are sold short. View Hill-Rom's Current Options Chain.

Who are some of Hill-Rom's key competitors?

What other stocks do shareholders of Hill-Rom own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hill-Rom investors own include Steel Dynamics (STLD), Walt Disney (DIS), Paypal (PYPL), Trade Desk (TTD), Square (SQ), Twilio (TWLO), Mastercard (MA), NVIDIA (NVDA), AK Steel (AKS) and Chipotle Mexican Grill (CMG).

Who are Hill-Rom's key executives?

Hill-Rom's management team includes the following people:
  • Mr. John P. Groetelaars, Pres, CEO & Director (Age 52)
  • Mr. Carlos Alonso-Marum, Sr. VP & Pres of International (Age 60)
  • Mr. Paul Johnson, Sr. VP & Pres of Patient Support Systems (Age 54)
  • Mr. Steven J. Strobel, Sr. Advisor (Age 61)
  • Ms. Barbara W. Bodem, Sr. VP & CFO (Age 51)

What is Hill-Rom's stock symbol?

Hill-Rom trades on the New York Stock Exchange (NYSE) under the ticker symbol "HRC."

How do I buy shares of Hill-Rom?

Shares of HRC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Hill-Rom's stock price today?

One share of HRC stock can currently be purchased for approximately $114.08.

How big of a company is Hill-Rom?

Hill-Rom has a market capitalization of $7.59 billion and generates $2.91 billion in revenue each year. The medical technology company earns $152.20 million in net income (profit) each year or $5.08 on an earnings per share basis. Hill-Rom employs 10,000 workers across the globe.

What is Hill-Rom's official website?

The official website for Hill-Rom is www.hill-rom.com.

How can I contact Hill-Rom?

Hill-Rom's mailing address is 130 East Randolph Street Suite 1000, Chicago IL, 60601. The medical technology company can be reached via phone at 312-819-7200 or via email at [email protected]

This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.